These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 25820824

  • 1. Interaction with CCNH/CDK7 facilitates CtBP2 promoting esophageal squamous cell carcinoma (ESCC) metastasis via upregulating epithelial-mesenchymal transition (EMT) progression.
    Zhang J, Zhu J, Yang L, Guan C, Ni R, Wang Y, Ji L, Tian Y.
    Tumour Biol; 2015 Sep; 36(9):6701-14. PubMed ID: 25820824
    [Abstract] [Full Text] [Related]

  • 2. Interaction with cyclin H/cyclin-dependent kinase 7 (CCNH/CDK7) stabilizes C-terminal binding protein 2 (CtBP2) and promotes cancer cell migration.
    Wang Y, Liu F, Mao F, Hang Q, Huang X, He S, Wang Y, Cheng C, Wang H, Xu G, Zhang T, Shen A.
    J Biol Chem; 2013 Mar 29; 288(13):9028-34. PubMed ID: 23393140
    [Abstract] [Full Text] [Related]

  • 3. Low expression of cyclinH and cyclin-dependent kinase 7 can decrease the proliferation of human esophageal squamous cell carcinoma.
    Zhang J, Yang X, Wang Y, Shi H, Guan C, Yao L, Huang X, Ding Z, Huang Y, Wang H, Cheng C.
    Dig Dis Sci; 2013 Jul 29; 58(7):2028-37. PubMed ID: 23456497
    [Abstract] [Full Text] [Related]

  • 4. CtBP2 contributes to malignant development of human esophageal squamous cell carcinoma by regulation of p16INK4A.
    Guan C, Shi H, Wang H, Zhang J, Ni W, Chen B, Hou S, Yang X, Shen A, Ni R.
    J Cell Biochem; 2013 Jun 29; 114(6):1343-54. PubMed ID: 23255392
    [Abstract] [Full Text] [Related]

  • 5. Transcriptional inhibition by CDK7/9 inhibitor SNS-032 suppresses tumor growth and metastasis in esophageal squamous cell carcinoma.
    Zeng H, Yang H, Song Y, Fang D, Chen L, Zhao Z, Wang C, Xie S.
    Cell Death Dis; 2021 Nov 05; 12(11):1048. PubMed ID: 34741018
    [Abstract] [Full Text] [Related]

  • 6. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
    Wang N, Liu F, Cao F, Jia Y, Wang J, Ma W, Tan B, Wang K, Song Q, Cheng Y.
    Cancer Biol Ther; 2015 Nov 05; 16(4):528-40. PubMed ID: 25719728
    [Abstract] [Full Text] [Related]

  • 7. LncRNA NEAT1 Regulates Cell Viability and Invasion in Esophageal Squamous Cell Carcinoma through the miR-129/CTBP2 Axis.
    Li Y, Chen D, Gao X, Li X, Shi G.
    Dis Markers; 2017 Nov 05; 2017():5314649. PubMed ID: 29147064
    [Abstract] [Full Text] [Related]

  • 8. CtBP2 interacts with TGIF to promote the progression of esophageal squamous cell cancer through the Wnt/β‑catenin pathway.
    Ju Q, Jiang M, Huang W, Yang Q, Luo Z, Shi H.
    Oncol Rep; 2022 Feb 05; 47(2):. PubMed ID: 34878149
    [Abstract] [Full Text] [Related]

  • 9. C-terminal binding protein‑2 mediates cisplatin chemoresistance in esophageal cancer cells via the inhibition of apoptosis.
    Shi H, Mao Y, Ju Q, Wu Y, Bai W, Wang P, Zhang Y, Jiang M.
    Int J Oncol; 2018 Jul 05; 53(1):167-176. PubMed ID: 29658564
    [Abstract] [Full Text] [Related]

  • 10. MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1.
    Yokobori T, Suzuki S, Tanaka N, Inose T, Sohda M, Sano A, Sakai M, Nakajima M, Miyazaki T, Kato H, Kuwano H.
    Cancer Sci; 2013 Jan 05; 104(1):48-54. PubMed ID: 23013135
    [Abstract] [Full Text] [Related]

  • 11. PURα mediates epithelial-mesenchymal transition to promote esophageal squamous cell carcinoma progression by regulating Snail2.
    Gao J, Tian L, Sun Y, Li W, Zhao L, Sun Y, Jing Z, Zhou L, Liu F, Zhao X.
    Cancer Lett; 2021 Feb 01; 498():98-110. PubMed ID: 33144099
    [Abstract] [Full Text] [Related]

  • 12. miR-25 mediates metastasis and epithelial-mesenchymal-transition in human esophageal squamous cell carcinoma via regulation of E-cadherin signaling.
    Liu B, Li X, Li C, Xu R, Sun X.
    Bioengineered; 2019 Dec 01; 10(1):679-688. PubMed ID: 31679450
    [Abstract] [Full Text] [Related]

  • 13. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A, Ainiwaer J, Hou Z, Niyaz M, Turghun A, Hasim A, Zhang H, Lu X, Sheyhidin I.
    J Cancer Res Clin Oncol; 2018 Jun 01; 144(6):1025-1035. PubMed ID: 29532228
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-145 Inhibits Cell Migration and Invasion and Regulates Epithelial-Mesenchymal Transition (EMT) by Targeting Connective Tissue Growth Factor (CTGF) in Esophageal Squamous Cell Carcinoma.
    Han Q, Zhang HY, Zhong BL, Wang XJ, Zhang B, Chen H.
    Med Sci Monit; 2016 Oct 23; 22():3925-3934. PubMed ID: 27771733
    [Abstract] [Full Text] [Related]

  • 15. LTBP1 promotes esophageal squamous cell carcinoma progression through epithelial-mesenchymal transition and cancer-associated fibroblasts transformation.
    Cai R, Wang P, Zhao X, Lu X, Deng R, Wang X, Su Z, Hong C, Lin J.
    J Transl Med; 2020 Mar 26; 18(1):139. PubMed ID: 32216815
    [Abstract] [Full Text] [Related]

  • 16. Upregulation of long noncoding RNA SPRY4-IT1 promotes metastasis of esophageal squamous cell carcinoma via induction of epithelial-mesenchymal transition.
    Zhang CY, Li RK, Qi Y, Li XN, Yang Y, Liu DL, Zhao J, Zhu DY, Wu K, Zhou XD, Zhao S.
    Cell Biol Toxicol; 2016 Oct 26; 32(5):391-401. PubMed ID: 27250657
    [Abstract] [Full Text] [Related]

  • 17. Downregulation of nicotinamide N-methyltransferase inhibits migration and epithelial-mesenchymal transition of esophageal squamous cell carcinoma via Wnt/β-catenin pathway.
    Cui Y, Zhang L, Wang W, Ma S, Liu H, Zang X, Zhang Y, Guan F.
    Mol Cell Biochem; 2019 Oct 26; 460(1-2):93-103. PubMed ID: 31278587
    [Abstract] [Full Text] [Related]

  • 18. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1.
    Wu D, He X, Wang W, Hu X, Wang K, Wang M.
    Mol Oncol; 2020 Sep 26; 14(9):2332-2351. PubMed ID: 32239639
    [Abstract] [Full Text] [Related]

  • 19. TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway.
    Shan B, Man H, Liu J, Wang L, Zhu T, Ma M, Xv Z, Chen X, Yang X, Li P.
    Oncol Rep; 2016 Sep 26; 36(3):1551-61. PubMed ID: 27430162
    [Abstract] [Full Text] [Related]

  • 20. Downregulation of LINC00886 facilitates epithelial-mesenchymal transition through SIRT7/ELF3/miR-144 pathway in esophageal squamous cell carcinoma.
    Dong Z, Yang L, Lu J, Guo Y, Shen S, Liang J, Guo W.
    Clin Exp Metastasis; 2022 Aug 26; 39(4):661-677. PubMed ID: 35616822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.